KGAUF yields 1000.00% · JNJ yields 2.13%● Live data
📍 KGAUF pulled ahead of the other in Year 1
Combined, KGAUF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of KGAUF + JNJ for your $10,000?
Kongsberg Automotive ASA develops, manufactures, and sells products to the automotive industry worldwide. The company operates through Powertrain & Chassis and Specialty Products segments. The Powertrain & Chassis segment designs, manufactures, and tests custom powertrain and chassis solutions, including gear shifters for automatic and manual transmissions, shift cables and towers, and vehicle dynamics products for cabins and axles, as well as gear and clutch control systems comprise of actuators. The Specialty Products segment offers fluid handling systems; couplings systems for compressed-air circuits in heavy-duty vehicles; and operator control systems for power sports construction, agriculture, outdoor power equipment, and power electronics products. It serves OEMs and Tier 1 suppliers in the automotive, commercial vehicle, and off-highway markets. The company was formerly known as Kongsberg Automotive Holding ASA and changed its name to Kongsberg Automotive ASA in August 2014. Kongsberg Automotive ASA was founded in 1957 and is based in Kongsberg, Norway.
Full KGAUF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.